Provided by Tiger Trade Technology Pte. Ltd.

Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)

8.98
-0.2700-2.92%
Post-market: 8.89-0.0900-1.00%19:30 EDT
Volume:567.15K
Turnover:5.15M
Market Cap:869.71M
PE:-4.61
High:9.41
Open:9.41
Low:8.95
Close:9.25
52wk High:11.06
52wk Low:3.30
Shares:96.85M
Float Shares:77.97M
Volume Ratio:0.66
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9500
EPS(LYR):-2.5505
ROE:-74.65%
ROA:-42.51%
PB:3.46
PE(LYR):-3.52

Loading ...

Application for Quotation of Securities - Avr-avr.o

Reuters
·
Jul 31

Anteris Technologies Global Corp-Cleansing Notice Update

THOMSON REUTERS
·
Jul 31

Cleansing Notice Update-AVR.O

Reuters
·
Jul 31

L1 Capital Reports Disposal of 23,000 Anteris Technologies Common Shares Valued at $186,990

Reuters
·
Jul 28

Notification Regarding Unquoted Securities - Avr-avr.o

Reuters
·
Jul 23

Anteris Technologies Seeks ASX Quotation for New AVR Securities

TIPRANKS
·
Jul 15

Application for Quotation of Securities - Avr-avr.o

Reuters
·
Jul 15

Notification Regarding Unquoted Securities - Avr-avr.o

Reuters
·
Jul 14

Form S-3 Registration Statement-avr.o

Reuters
·
Jul 02

Anteris Technologies Files Offering of Up to 5.39 Million Shares

MT Newswires Live
·
Jul 02

Anteris Technologies files to sell 5.39M shares of common stock

TIPRANKS
·
Jul 02

Application for quotation of securities - AVR-AVR.O

Reuters
·
Jun 24

Change of Director's Interest Notice-AVR.O

Reuters
·
Jun 22

Anteris Technologies Global Corp-Paradigm - French Regulatory Clearance

THOMSON REUTERS
·
Jun 09

PARADIGM - French Regulatory Clearance-AVR.O

Reuters
·
Jun 09

Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis

MT Newswires Live
·
Jun 08

Anteris Technologies cleared by ANSM for DurAVR THV trial

TIPRANKS
·
Jun 08

Anteris Technologies Global - Receives French Regulatory Clearance for Duravr Transcatheter Heart Valve Global Trial

THOMSON REUTERS
·
Jun 08

Anteris wins French ANSM clearance for DurAVR transcatheter valve PARADIGM trial

Reuters
·
Jun 08

Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

GlobeNewswire
·
Jun 08